Nassar El Assaad, Research Fellow at MD Anderson Cancer Center, shared on LinkedIn:
”Honored to present our work on immune checkpoint blockade in advanced/metastatic leiomyosarcoma at the American Association for Cancer Research (AACR) Rare Cancers Conference in Vancouver, Canada.
A special thank you to Dr. Elise Nassif Haddad for her mentorship and continuous guidance, and to the entire UT MD Anderson Sarcoma Medical Oncology team for their invaluable insights, support, and contributions in shaping this project. Looking forward to publishing this work and continuing to build on these findings.”
Other articles about AACR on OncoDaily.